All filters
Videos
European Meeting | Covid-19 Sattelite: Abstract #33 - Mohammad Alkhatib
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
European Meeting | Session 4: Abstract #11 - Velia Chiara Di Maio
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
European Meeting | Session 3: Abstract #9 - Kristen Andreatta
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
European Meeting Session 2: Abstract Driven Presentations
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
European Meeting Session 1: Abstract Driven Presentations
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Breaking Bad: Chems, Sex And Sexual Health
M. Reiriz Rojas
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Determination Of Drug Resistance Of Hepatitis C Virus To NS5A Protein Inhibitors As A New Approach To Personalized Medicine
E. Gasich
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Using Next-Generation Sequencing To Assess The Differences In HIV Drug Resistance Pre- And Post-Treatment In A Treatment As Prevention Trial
S. Kemp
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Association Of Viral Reservoir With HIV Infection Duration, Viral Load And CD4 Count
D. Kireev
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Creation Of An Italian HIV Dna Network For The Validation And Clinical Use Of HIV-1 DNA Quantification Assays
I. Vicenti
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Exploratory Evaluation For The Optimization Of Next Generation Sequencing HIV-1 Drug Resistance Outcomes Based On An In-House RNA Extraction Protocol
A. Orta-Resendiz
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Associations Between Vitamin D And Fibrosis, Genotype, Viral Load In Patients Having Chronic Hepatitis C
M. Nikolaichuk
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The Quantification Of HBeAg Levels Differ Among The Different Phases Of Hbv Infection, And Can Predict Therapeutic Outcome In The Setting Of Immunosuppression Driven Hbv Reactivation
L. Piermatteo
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Combined Use Of High-Sensitivity Serological And Virological Hbv Markers Can Make Better In Predicting The Occurrence Of HBV Reactivation And To Optimize Prophylaxis Duration In HBsAg-Negative/Anti-HBc-Positive Patients In The Context Of Oncohematological
M. Alkhatib
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The Effectiveness Of The Application Of Serological Tests And Laboratory Indicators As Part Of Rita For The Detection Of Recent HIV Infection
A. Murzakova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Ibalizumab Shows In Vitro Activity Against Group A And Group B HIV-2 Clinical Isolates
C. Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
TDF Surveillance And Clinically Relevant Resistance In Spain: 2019 Update
F. García
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HCV Resistance Associated Variants Following Directly Acting Agent Therapy Failure- Real Life Data From Poland
M. Parczewski
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence Of Transmitted Resistance Mutations To Rilpivirine And Doravirine In Treatment-Naive Patients In A Large Clinical And Resistance Database
F. Lombardi
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Absence Of GS-6207 Phenotypic Resistance In HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, And Isolates With Resistance To Existing Drug Classes
N. Margot
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Susceptibility To Bnabs Of Transmitted HIV Variants Among Recent Infections In France
K. Stefic
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Genotyping And Treatment Issues With Unusual 1E And 1G HCV Subtypes From African Subjects: Report Of Two Cases
C. Caudai
Presented at:
European Meeting on HIV & Hepatitis 2020